Translating Aging

Translating Aging

Biotechnology

San Francisco, CA 1,742 followers

A podcast about the people advancing longevity science & developing drugs to extend human healthspan. Produced by BioAge

About us

Translating Aging is a podcast about how the science of human longevity is transforming the way we treat disease. In each episode, we bring you conversations with the researchers, entrepreneurs, and investors who are working at the vanguard of the field. Translating Aging is produced by BioAge Labs, a clinical-stage biotechnology company developing therapies to extend healthy lifespan by targeting the molecular causes of aging.

Website
https://bioage.captivate.fm
Industry
Biotechnology
Company size
2-10 employees
Headquarters
San Francisco, CA
Type
Privately Held
Founded
2021

Locations

Employees at Translating Aging

Updates

  • View organization page for Translating Aging, graphic

    1,742 followers

    We’re gratified to see Translating Aging at the top of the list of aging & longevity podcasts at AgingBiotech.info. Many thanks to our friend Karl R. Pfleger for compiling and updating this incredible resource for anyone seeking to learn more about the latest in geroscience and longevity biotech. As we gear up for the 2024 season — our fourth! — now is a great time to check out our back episodes. (Our most recent show, an interview with aging pioneer Cynthia Kenyon, is a good place to start for newcomers seeking historical background on our field!) New content coming soon, so make sure you're subscribed. Thanks for listening! https://lnkd.in/gb9x5pYe

    View profile for Karl R. Pfleger, graphic

    Founder, AgingBiotech.info. Investor, rejuvenation biotech (only; don't pitch me on other stuff).

    Announcing a big update of a small list: List of podcasts in the aging/longevity biotech field at AgingBiotech.info -> podcasts just overhauled: - several new shows added (up to 24 total now) - clearer description of to what extent each is topically on-target for aging biotech - global popularity score & counts of ratings on the major podcast platforms as backups - recency score based on months since last episode - aggregate ranking combining the above (default sort) Manually sortable by any column (like all the tables on the site). Direct link (that LinkedIn will prob shorten): https://lnkd.in/gsauUtpM There's a tradeoff between topicality & popularity here: The hard science & biotech (focusing on what's coming) doesn't have as broad an appeal as the health optimization with what's available now (lifestyle & current clinical practice) stuff. I've structured the rankings so that topicality is weighted more highly so that the stuff focused on the science of aging biology as it pertains to biotech development of next-generation interventions (the main focus of the site) is what goes to the top, but everything gets lowered if the podcast ends and gets increasingly out of date. This list is not meant to be comprehensive with respect to the health optimization type podcasts. There are too many, but the ones included are particularly notable or do dip their toes enough into aging & longevity for inclusion.

    Aging Podcasts

    agingbiotech.info

  • View organization page for Translating Aging, graphic

    1,742 followers

    “We believe every human has the right to live a longer, healthier life.” The Hevolution Foundation is a global non-profit organization that funds research and entrepreneurship in healthspan science, and has already become a major force in the field. This week on Translating Aging, Hevolution CEO Mehmood Khan tells the story of the foundation’s origins, its mission, and his vision for how the science of aging can revolutionize health care around the world. Translating Aging is produced by BioAge Labs, a clinical-stage biotechnology company that is harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases. Episode: https://lnkd.in/g3Jw4tyc (click ‘FOLLOW’ for links to your favorite podcast platform) Podcast: https://lnkd.in/gvF4X-ka

    • No alternative text description for this image
  • View organization page for Translating Aging, graphic

    1,742 followers

    In this week's episode, Hans Keirstead of Immunis, Inc. shares how his company is developing novel secretome-based therapeutics to restore youthful immune function, with the goal of treating a wide range of age-related conditions — including muscle loss and obesity — while extending overall healthspan. Translating Aging is produced by BioAge Labs, a clinical-stage biotechnology company that is harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases. 🎧: Episode: https://lnkd.in/gesMqMgX Links to the major podcast platforms:  • Apple Podcasts: https://lnkd.in/gg-9m8H7 • Google Podcasts: https://lnkd.in/gBm4zft9 • Spotify: https://lnkd.in/ge4wzJPY

    • No alternative text description for this image
  • View organization page for Translating Aging, graphic

    1,742 followers

    Age-related decline in ovarian function leads to adverse health outcomes. In this episode, Daisy Robinton, PhD tells us how her company Oviva Therapeutics is aiming to extend women’s healthspan through developing novel therapeutics that target ovarian function and longevity. Translating Aging is produced by BioAge Labs, a clinical-stage biotechnology company that is harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases. Episode: https://lnkd.in/gv7Aqf9A (click ‘FOLLOW’ for links to your favorite podcast platform) Podcast: https://lnkd.in/gvF4X-ka

    • No alternative text description for this image
  • View organization page for Translating Aging, graphic

    1,742 followers

    Chronic diseases are the leading causes of death and disability in America, and they are also a leading driver of healthcare costs. In this episode, Dr. Noah Davidsohn, CSO and co-founder of Rejuvenate Bio, describes his company’s gene therapy approach to treating chronic age-related disease. Translating Aging is produced by BioAge Labs, a clinical-stage biotechnology company that is harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases. Episode: https://lnkd.in/gghfCYCg (click ‘FOLLOW’ for links to your favorite podcast platform) Podcast: https://lnkd.in/gvF4X-ka

    • No alternative text description for this image
  • View organization page for Translating Aging, graphic

    1,742 followers

    Thirty years ago this week, Cynthia Kenyon published a groundbreaking paper entitled “A C. elegans mutant that lives twice as long as wild type”—revealing that lifespan is under genetic control. That study, along with others published around the same time, have led some observers of the field to identify the early 90s as the dawn of the modern biology of aging. In this episode, Dr. Kenyon shares her perspective on how our field has grown and changed over the past three decades. Translating Aging is produced by BioAge Labs, a clinical-stage biotechnology company developing drugs to treat human disease and extend healthspan by targeting the molecular mechanisms of aging. Episode: https://lnkd.in/gnYSeHWV (click ‘FOLLOW’ for links to your favorite podcast platform) Podcast: https://lnkd.in/gvF4X-ka

    • No alternative text description for this image
  • View organization page for Translating Aging, graphic

    1,742 followers

    Today, XPRIZE launched its largest-ever competition - a $101 million prize for a team that can develop a therapeutic that restores muscle, cognition, and immune function by at least 10 years. In this episode, we talk with Jamie Justice, Ph.D., Executive Director of XPRIZE Healthspan, about  the motivation, structure, and timeline of the prize—as well as how teams can get involved. Translating Aging is produced by BioAge Labs, a clinical-stage biotechnology company developing drugs to treat human disease and extend healthspan by targeting the molecular mechanisms of aging. Episode: https://lnkd.in/gJGXRfeR (click ‘FOLLOW’ for links to your favorite podcast platform) Podcast: https://lnkd.in/gvF4X-ka

    • No alternative text description for this image
  • View organization page for Translating Aging, graphic

    1,742 followers

    Listeners in the Boston area, take note. You might hear a familiar voice in the crowd....

    View organization page for BioAge Labs, graphic

    12,780 followers

    Please join BioAge at our next longevity biotech networking event in the Boston area—bringing together a community of innovators working to translate insights from aging biology into new medicines to treat disease and extend healthspan and lifespan. This event, co-sponsored with our friends Hevolution Foundation, will feature a fireside chat with Professor Vadim Gladyshev, a leading researcher in the biology of aging. We’re expecting a stellar crowd of scientists, entrepreneurs, and investors — as well as refreshments and ample time to network!    Nov 6, 2023 • 6–8 PM RSVP for location https://lu.ma/e4em1nqq   Have a wonderful weekend, and we look forward to seeing you there!

    Longevity Biotech mixer · Luma

    Longevity Biotech mixer · Luma

    lu.ma

  • View organization page for Translating Aging, graphic

    1,742 followers

    Professor Coleen Murphy is the author of the upcoming book “How Do We Age? The Science of Longevity” — the latest deep dive into the subject by a prominent biologist of aging. In this episode, Dr. Murphy shares her motivation for writing this book, the thinking behind her choice of topics, and her unique perspective on the field. Translating Aging is produced by BioAge Labs, a clinical-stage biotechnology company developing drugs to treat human disease and extend healthspan by targeting the molecular mechanisms of aging. Episode: https://lnkd.in/gsWid5Mj (click ‘FOLLOW’ for links to your favorite podcast platform) Podcast: https://lnkd.in/gvF4X-ka

    • No alternative text description for this image
  • View organization page for Translating Aging, graphic

    1,742 followers

    Last week, pharma giant AbbVie announced that it had acquired Mitokinin Inc, a Bay Area–based startup developing treatments for Parkinson’s disease. In this episode, we talk with Mitokinin CSO and co-founder Nicholas Hertz, Ph.D about his journey from discovery to startup to exit — and what comes next. Translating Aging is produced by BioAge Labs, a clinical-stage biotechnology company developing drugs to treat human disease and extend healthspan by targeting the molecular mechanisms of aging. Episode: https://lnkd.in/gdQ3dCfd (click ‘FOLLOW’ for links to your favorite podcast platform) Podcast: https://lnkd.in/gvF4X-ka

    • No alternative text description for this image

Similar pages

Browse jobs